Posted on

FDA expands eligibility for Pfizer Covid booster shots to 16- and 17-year-olds amid omicron fears



Share

The FDA authorization comes a day after Pfizer released lab data indicating that booster shots provide high levels of protection against the omicron variant.

Read More